Global Over-The-Counter (OTC) Pain Relievers Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Over-The-Counter (OTC) Pain Relievers Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Over-the-counter pain relivers are a wide range of drugs which can be purchased without physician prescriptions and are used for acute pain-related conditions.
Over-The-Counter (OTC) Pain Relievers report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Over-The-Counter (OTC) Pain Relievers market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Over-The-Counter (OTC) Pain Relievers industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Over-The-Counter (OTC) Pain Relievers key manufacturers include Pfizer, Johnson and Johnson, Bayer, GlaxoSmithKline, Taisho Pharmaceutical, Teva Pharmaceutical, Merck, Cardinal Health and Sanofi, etc. Pfizer, Johnson and Johnson, Bayer are top 3 players and held % sales share in total in 2022.
Over-The-Counter (OTC) Pain Relievers can be divided into Non-Steroidal Anti-Inflammatory Drugs, Local Anaesthetics and Acetaminophen,, etc. Non-Steroidal Anti-Inflammatory Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Over-The-Counter (OTC) Pain Relievers is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Over-The-Counter (OTC) Pain Relievers industry development. In 2022, global % sales of Over-The-Counter (OTC) Pain Relievers went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Over-The-Counter (OTC) Pain Relievers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Pfizer
Johnson and Johnson
Bayer
GlaxoSmithKline
Taisho Pharmaceutical
Teva Pharmaceutical
Merck
Cardinal Health
Sanofi
Sun Pharmaceutical
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Local Anaesthetics
Acetaminophen
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Over-The-Counter (OTC) Pain Relievers market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Over-The-Counter (OTC) Pain Relievers, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Over-The-Counter (OTC) Pain Relievers industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Over-The-Counter (OTC) Pain Relievers in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Over-The-Counter (OTC) Pain Relievers introduction, etc. Over-The-Counter (OTC) Pain Relievers Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Over-The-Counter (OTC) Pain Relievers market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Over-The-Counter (OTC) Pain Relievers report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Over-The-Counter (OTC) Pain Relievers market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Over-The-Counter (OTC) Pain Relievers industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Over-The-Counter (OTC) Pain Relievers key manufacturers include Pfizer, Johnson and Johnson, Bayer, GlaxoSmithKline, Taisho Pharmaceutical, Teva Pharmaceutical, Merck, Cardinal Health and Sanofi, etc. Pfizer, Johnson and Johnson, Bayer are top 3 players and held % sales share in total in 2022.
Over-The-Counter (OTC) Pain Relievers can be divided into Non-Steroidal Anti-Inflammatory Drugs, Local Anaesthetics and Acetaminophen,, etc. Non-Steroidal Anti-Inflammatory Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Over-The-Counter (OTC) Pain Relievers is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Over-The-Counter (OTC) Pain Relievers industry development. In 2022, global % sales of Over-The-Counter (OTC) Pain Relievers went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Over-The-Counter (OTC) Pain Relievers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Pfizer
Johnson and Johnson
Bayer
GlaxoSmithKline
Taisho Pharmaceutical
Teva Pharmaceutical
Merck
Cardinal Health
Sanofi
Sun Pharmaceutical
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Local Anaesthetics
Acetaminophen
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Over-The-Counter (OTC) Pain Relievers market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Over-The-Counter (OTC) Pain Relievers, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Over-The-Counter (OTC) Pain Relievers industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Over-The-Counter (OTC) Pain Relievers in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Over-The-Counter (OTC) Pain Relievers introduction, etc. Over-The-Counter (OTC) Pain Relievers Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Over-The-Counter (OTC) Pain Relievers market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
